Publication:
Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae - Authors' reply.

No Thumbnail Available

Date

2017

Authors

Gutierrez-Gutierrez, Belen
Bonomo, Robert A
Carmeli, Yehuda
Paterson, David L
Pascual, Alvaro
Rodriguez-Baño, Jesus

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

The Lancet Publishing Group
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

We thank Bernd Salzberger and Gerd Fätkenheuer for their interest in our study.1 They were concerned about the use of Charlson, Pitt, and INCREMENT-CPE scores, as well as the individual variables contained in them in the analyses. Our objective was to provide the best possible estimation of the association of the main exposure ( treatment ) with the outcome considering the effect of confounders, in accordance with the study hypothesis; we did not intend to provide a model to predict outcome ( mortality ). Therefore, we did several multivariate analyses , including models with the individual variables, models with the scores, and models with both, after checking for collinearity. The best models were selected and are shown in tables 2 and 3 of our paper .1 As a result, when the scores were considered, the individual variables were not relevant and the effect of treatment on mortality was adjusted by the scores.

Description

MeSH Terms

Bacteremia
Carbapenem-Resistant Enterobacteriaceae
Enterobacteriaceae Infections
Microbial Sensitivity Tests

DeCS Terms

Mortalidad
Terapéutica
Análisis multivariante
Papel
Reflujo gastroesofágico
Asociación

CIE Terms

Keywords

Anti-Bacterial Agents, Bacterial Proteins, Enterobacteriaceae, Humans, beta-Lactamases

Citation

Gutiérrez-Gutiérrez B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J. Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae - Authors' reply. Lancet Infect Dis. 2017 Oct;17(10):1020-1021.